Effects of Dry Needling on Stiffness in Latent Trigger Points

September 30, 2020 updated by: University of Castilla-La Mancha

Effects of Dry Needling on Stiffness in Latent Myofascial Trigger Points: a Randomized Controlled Trial

The purpose of this study is to determine whether application of Dry Needling (DN) is effective for reduced on Stiffness in Latent trigger point (LTrP) of upper trapezius. The secondary purposes are to determine the correlation on two elastography for stiffness measure (Shear-wave elastography and Strain elastography). Randomized controlled trial, in parallel with cross-control design. Two groups with LTrP in upper trapezius, and will be randomly selected to DN group or Sham-Dn group.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Study Type

Interventional

Enrollment (Actual)

51

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • Spain
      • Toledo, Spain, 45071
        • Performance and Sport Rehabilitation Laboratory

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 30 years (Adult)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Age between 18 and 30 years
  • The presence of LTrP in the middle third of the upper trapezius muscle on the dominant side
  • Being able to provide written informed consent
  • Being able to follow instructions and realize clinical tests

Exclusion Criteria:

  • Any pharmacological therapeutic
  • Any medical treatment or physical therapies at cervical region during the 6-month before this study - Any diagnosed health problem
  • Any history of head and upper extremity surgery or trauma
  • Any red flags to DN, (ie: metabolic diseases, pregnancy, kinesiophobia, Infection, cancer)
  • Absence of recurrent history of neck pain
  • No neck pain symptomatology the previous 6 months
  • Cervical disk herniation

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Double

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Deep Dry Needling
Intervention-Dry Needling: Deep Dry Needing into the latent trigger point of the upper trapezius muscle
Device: Intervention-Dry Needling

Deep Dry Needling into the site of the latent Trigger Point of the upper trapezius muscle.

1 session in upper trapezius muscle moving the needle up and down ten times.
Sham Comparator: Sham Dry Needling
Control-Dry Needling: Sham Dry Needling into the latent trigger point of the upper trapezius muscle
Device: Intervention-Dry Needling

Deep Dry Needling into the site of the latent Trigger Point of the upper trapezius muscle.

1 session in upper trapezius muscle moving the needle up and down ten times.

Device: Control-Dry Needling

Sham Dry Needling into the site of the latent Trigger Point of the upper trapezius muscle with non-penetrating needles

1 session in upper trapezius muscle moving the needle up and down ten times.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change on Stiffness (Shear wave elastography and Strain Elastography)
Time Frame: Baseline, at 30 minutes after treatment, at 24 hours after treatment, at 72 hours after treatment

Shear-wave Elastography (SWE) as assessed using an Logiq S8 US system (GE Healthcare).

The stiffness was determined with measuring velocity of shear waves in trapezius muscle on SWE exam.

Strain elastography (SEL) as assessed using an Logiq S8 US system (GE Healthcare).

The stiffness was determined by applying light repetitive compression with the hand-held transducer
Baseline, at 30 minutes after treatment, at 24 hours after treatment, at 72 hours after treatment

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in Pain Pressure Threshold (PPT)
Time Frame: Baseline, at 30 minutes after treatment, at 24 hours after treatment, at 72 hours after treatment
Pressure-Pain Threshold as assessed by an manual mechanical algometer. PPT is the minimal amount of pressure that produces pain and is used to assess abnormalities in nociceptive processing or hyperalgesia.
Baseline, at 30 minutes after treatment, at 24 hours after treatment, at 72 hours after treatment
Change in Thickness of muscle
Time Frame: Baseline, at 30 minutes after treatment, at 24 hours after treatment, at 72 hours after treatment
The muscle was scanned in the longitudinal and axial planes, taking care to avoid anisotropy. B-Mode gray scale was employed to measure muscle thickness
Baseline, at 30 minutes after treatment, at 24 hours after treatment, at 72 hours after treatment
Change in Post-needling soreness
Time Frame: Baseline, at 30 minutes after treatment, at 24 hours after treatment, at 72 hours after treatment
The procedure performed was the subject had to characterize the level of pain using a visual analog scale (VAS), ranging from 0mm (no pain) to 10mm (worst imaginable pain)
Baseline, at 30 minutes after treatment, at 24 hours after treatment, at 72 hours after treatment

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

University of Castilla-La Mancha

Investigators

  • Study Director: Javier Abián-Vicén, PhD, Castilla-La Mancha University

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

June 1, 2020

Primary Completion (Actual)

July 31, 2020

Study Completion (Actual)

August 31, 2020

Study Registration Dates

First Submitted

May 10, 2020

First Submitted That Met QC Criteria

May 14, 2020

First Posted (Actual)

May 19, 2020

Study Record Updates

Last Update Posted (Actual)

October 5, 2020

Last Update Submitted That Met QC Criteria

September 30, 2020

Last Verified

September 1, 2020

More Information

Terms related to this study

Keywords

Other Study ID Numbers

  • DNStiffness

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Trigger Points

Clinical Trials on Intervention-Dry Needling

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in United States

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

3
Subscribe